Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
20.3M
-
Shares change
-
+6.26M
-
Total reported value, excl. options
-
$139M
-
Value change
-
+$43.2M
-
Number of buys
-
25
-
Number of sells
-
-4
-
Price
-
$6.90
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q3 2020
33 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q3 2020.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.3M shares
of 47.6M outstanding shares and own 42.68% of the company stock.
Largest 10 shareholders include Blackstone Group Inc (3.57M shares), BVF INC/IL (3.01M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.34M shares), Avidity Partners Management LP (2.09M shares), Soleus Capital Management, L.P. (1.83M shares), Vivo Capital, LLC (1.52M shares), ORBIMED ADVISORS LLC (1.18M shares), Omega Fund Management, LLC (913K shares), Sio Capital Management, LLC (656K shares), and JANUS HENDERSON GROUP PLC (476K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.